Overview
- 4 inspections across 4 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-04-05.
At a glance
Inspections
4
Sites
4
Observations
0
Career since
Feb 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Adaptimmune LLC | 5 Apr 2024 | Biologics | On file |
| Oxford Biomedica (US) LLC | 16 Feb 2024 | Biologics | On file |
| Krystal Biotech, Inc. | 16 Nov 2022 | Biologics | On file |
| Lonza Houston, Inc | 18 Feb 2022 | Biologics |
Sites inspected
Adaptimmune LLCPhiladelphia, United States1 insp.
Oxford Biomedica (US) LLCDurham, United States1 insp.
Krystal Biotech, Inc.Pittsburgh, United States1 insp.
Lonza Houston, IncHouston, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Wei Wang2 shared
Elvira R Argus1 shared
Laura K Demaster1 shared
Viviana R Ramirez1 shared
Sharmila Shrestha1 shared
Jie He1 shared
Jianyang Wang1 shared
Jakob Reiser1 shared
Carl A Perez1 shared
Bo Liang1 shared
Full investigator report
Get the verbatim findings behind Anna R Kwilas' inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site